Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 17, 2023

BUY
$57.89 - $64.73 $9,204 - $10,292
159 Added 4.52%
3,674 $213,000
Q1 2022

May 05, 2022

SELL
$61.48 - $73.72 $6,148 - $7,372
-100 Reduced 2.77%
3,515 $257,000
Q4 2021

Feb 15, 2022

BUY
$53.63 - $62.52 $5,363 - $6,252
100 Added 2.84%
3,615 $225,000
Q3 2020

Oct 30, 2020

SELL
$57.43 - $63.64 $1,435 - $1,591
-25 Reduced 0.71%
3,515 $212,000
Q2 2020

Aug 10, 2020

BUY
$54.82 - $64.09 $194,062 - $226,878
3,540 New
3,540 $208,000
Q1 2020

May 08, 2020

SELL
$46.4 - $67.43 $154,326 - $224,272
-3,326 Closed
0 $0
Q4 2019

Feb 12, 2020

BUY
$49.21 - $64.19 $163,672 - $213,495
3,326 New
3,326 $213,000
Q1 2019

Apr 16, 2019

SELL
$45.12 - $53.8 $186,390 - $222,247
-4,131 Closed
0 $0
Q4 2018

Jan 28, 2019

SELL
$48.76 - $63.23 $9,849 - $12,772
-202 Reduced 4.66%
4,131 $215,000
Q3 2018

Oct 22, 2018

BUY
$55.19 - $62.25 $11,148 - $12,574
202 Added 4.89%
4,333 $269,000
Q1 2018

Apr 18, 2018

SELL
$59.92 - $68.98 $2,396 - $2,759
-40 Reduced 0.96%
4,131 $261,000
Q4 2017

Feb 02, 2018

SELL
$59.94 - $65.35 $4,195 - $4,574
-70 Reduced 1.65%
4,171 $256,000
Q3 2017

Nov 08, 2017

BUY
$55.23 - $63.74 $234,230 - $270,321
4,241
4,241 $270,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Armbruster Capital Management, Inc. Portfolio

Follow Armbruster Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Armbruster Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Armbruster Capital Management, Inc. with notifications on news.